Drug Shortage Report for PRO-NAPROXEN EC
Report ID | 37653 |
Drug Identification Number | 02310953 |
Brand name | PRO-NAPROXEN EC - 500 |
Common or Proper name | NAPROXEN EC - 500 |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | NAPROXEN |
Strength(s) | 500MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-06-27 |
Estimated end date | |
Actual end date | 2019-10-30 |
Shortage status | Resolved |
Updated date | 2019-10-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2019-10-31 | French | Compare |
v10 | 2019-10-31 | English | Compare |
v9 | 2018-06-28 | English | Compare |
v8 | 2018-06-27 | French | Compare |
v7 | 2018-06-27 | English | Compare |
v6 | 2018-04-05 | English | Compare |
v5 | 2018-04-04 | French | Compare |
v4 | 2018-04-04 | English | Compare |
v3 | 2018-01-31 | English | Compare |
v2 | 2018-01-30 | French | Compare |
v1 | 2018-01-30 | English | Compare |
Showing 1 to 11 of 11